Clinical trials
Oncology clinical trials
Below are recruiting oncology clinical trials, each written for real people, not researchers. We’re tracking 796 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06920342Recruiting
Study on gynecologic cancer care location preferences
This study asks women who are being checked for or have been diagnosed with a gynecologic cancer about where they prefer to receive their care. Your answers could help shape future services.
Taunton, SomersetAges 18 years+ - NCT06876714RecruitingPhase 3
Shorter vs Longer HER2 Therapy for Breast Cancer with Complete Response
This trial compares 6 months versus 12 months of HER2-targeted therapy for people with HER2+ breast cancer who had a complete response after chemo and trastuzumab. The goal is to see if a shorter treatment is just as effective.
Phoenix, ArizonaAges 18 years+ - NCT06321679Recruiting
Study of bone scans for advanced prostate cancer treatment
This trial is testing how well treatments for advanced prostate cancer that has spread to the bones can be seen on scans. It may help doctors find better ways to measure if the cancer is responding to treatment.
MilanAges 18 years+ - NCT07306338Recruiting
Integrative oncology program interest survey at USC Norris
This trial asks patients about their interest in an integrative oncology program combining standard cancer care with complementary therapies like nutrition or acupuncture to improve well-being.
Los Angeles, CaliforniaAges 18 years+ - NCT06900179Enrolling by invitation
Augmented reality education for cancer wound care nurses
This trial tests whether using augmented reality (a technology that adds digital information to what you see) can help nurses learn how to manage cancerous wounds that have a bad odor or discharge. If you are an oncology nurse at a teaching hospital in northern Taiwan, you may be able to join and learn new ways to care for these wounds.
New Taipei City, New Taipei CityAges 20 years+ - NCT05884073Recruiting
Exercise training for cancer care professionals
This trial is about using low- to moderate-intensity exercise to support people who professionally care for patients with cancer. It aims to see whether building this exercise approach is practical and safe for oncology care teams, starting with care professionals in Halifax.
Halifax, Nova ScotiaAges 18 years+ - NCT05896020RecruitingPhase 2
Test drug SHR-A1811 for gynecologic cancers
This Phase 2 trial tests SHR-A1811, a cancer medicine, in people with advanced or returning cervical, ovarian, or endometrial cancer. It may help shrink tumors, depending on whether you meet study safety and eligibility requirements.
Jinan, ShandongAges 18–75 - NCT06600295Recruiting
Taste changes and nutrition in new cancer patients
This study looks at how cancer and its treatments affect taste and nutrition. It aims to find ways to help patients maintain good nutrition during treatment.
DijonAges 18 years+ - NCT05472259RecruitingPhase 2
Testing two chemotherapy combos for metastatic pancreatic cancer
This Phase 2 study compares two chemotherapy combinations to treat metastatic pancreatic cancer that has progressed after gemcitabine (with or without Abraxane). It aims to see which combination works better and is tolerable for people with measurable disease.
Antwerp, AntwerpAges 18 years+ - NCT06545292Recruiting
Blood monitoring for cancer drugs using a finger prick
This study tests an easier way to measure the amount of cancer medicine in your blood using a simple finger prick instead of a standard blood draw. If you are taking one of the listed oral or IV cancer drugs, you may be able to participate.
Leiden, South HollandAges 18–90 - NCT05994690RecruitingPhase 3
Newly diagnosed pediatric AML trial with extra treatment options
This trial studies different treatment plans for children and teens newly diagnosed with AML (a type of blood cancer). Depending on the child's tumor markers and risk group, they may be offered an extra drug (quizartinib) or a targeted antibody (Mylotarg) to see if it improves outcomes.
Utrecht, UtrechtAges 1 day–18 years - NCT06511401Recruiting
Pain treatment guided by your genes
This study looks at whether knowing your genetic makeup can help doctors choose the safest and most effective pain medicine for you before you start taking opioids. If you are being treated for cancer and may need opioid pain medication soon, this trial might be a fit.
Chicago, IllinoisAges 18 years+ - NCT06403618Recruiting
Testing PreCursor-M+® for CIN2 management
This study tests a new tool called PreCursor-M+® to see how well it helps doctors manage CIN2, a moderate cervical cell change. It’s for people who have already been diagnosed with CIN2 and know their HPV test results.
MilanAges 18 years+ - NCT06333587Recruiting
Minimally invasive thyroid treatments for small thyroid cancer
This trial is testing less invasive treatments for a very small, slow-growing type of thyroid cancer (papillary thyroid microcarcinoma). If you have this specific cancer and are a candidate for a non-surgical procedure, the study will check how well these treatments work.
MilanAges 18 years+ - NCT06199427RecruitingPhase 2
Preventing graft-versus-host disease after stem cell transplant for immune disorders
This trial tests a combination of two drugs, ruxolitinib and PTCy, to prevent graft-versus-host disease (a common complication) in children receiving a stem cell transplant for inborn errors of immunity. The goal is to make the transplant safer and more effective.
MoscowAges birth–21 years - NCT07231913Recruiting
Emotional awareness training for oncology nurses
This study tests a training program designed to help oncology nurses improve their emotional awareness and communication skills. It may benefit nurses who want to feel more confident and effective in talking with patients and colleagues.
Ankara, YenimahalleAges 18 years+ - NCT07723261Recruiting
Testing NalIriFOx as first treatment for metastatic pancreatic cancer
This trial is testing a drug combination called NalIriFOx as the first treatment for people with pancreatic cancer that has spread. The goal is to see if it is safe and works well over the long term.
AthensAges 18 years+ - NCT06380309RecruitingEarly Phase 1
Study of experimental drug IDOV-SAFE for advanced digestive cancers
This trial tests an investigational drug for people with advanced digestive system cancers (like colorectal, stomach, or liver cancer) that have stopped responding to standard treatments. The goal is to see if the drug is safe and helps control the cancer.
BeijingAges 18–75 - NCT06790264Recruiting
Special PET Scan for Breast Cancer - FAPi Imaging
This trial uses a special PET scan (68Ga-FAPi-46) to see how breast cancer interacts with nearby cells. It may help doctors understand your tumor better and guide treatment decisions, especially if you are planning surgery or chemotherapy before surgery.
Milan, ItalyAges 18 years+ - NCT07713550Recruiting
Genetic profiling to guide treatment for advanced solid tumors
This study tests whether analyzing the DNA of your tumor (from a tissue sample or blood draw) can help find the best treatment for your advanced cancer. Researchers will look for genetic changes that could make you eligible for targeted therapy or a clinical trial.
AnderlechtAges 18 years+ - NCT07546136Recruiting
Fertility Preservation Before Cancer Treatment
This study helps people with cancer preserve their fertility (ability to have biological children) before undergoing cancer treatment that could affect their eggs or sperm. The trial compares two different hormone-injection methods to prepare eggs for freezing.
Bologna, BolognaAges 18–46 - NCT07546825Recruiting
Minimally invasive versus open surgery for endometrial cancer staging
This trial compares two surgical approaches for treating endometrial cancer: traditional open surgery (laparotomy) versus minimally invasive keyhole surgery (laparoscopy). The goal is to determine which method is safer and more effective for removing the uterus, ovaries, and lymph nodes while staging the cancer.
AsyutAges Any age - NCT07490548Enrolling by invitation
Lifestyle, mental health, and quality of life in childhood cancer survivors
This trial looks at how following a healthy lifestyle affects mental well-being and quality of life in children and teens who have finished cancer treatment. It is meant for those who are now coming back for follow-up visits.
CuencaAges 3–17 - NCT07505498Recruiting
Cancer patient support needs survey
This trial uses a short questionnaire to find out what kind of help and support cancer patients need, so care can be improved.
GöttingenAges 18 years+
Hear when a new Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for oncology?
- Yes. Clin2 currently lists 796 recruiting oncology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a oncology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a oncology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.